FDA to weigh easing limits on peptide injections, a treatment favored by RFK Jr. and other MAHA figures Anchorage Daily News FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower Extremity IschemiaReperfusion Injury